Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Sunshine Act

Business briefs: Reps mum on adverse events; FCC's new mHealth director; med schools tighten speaking limits

April 11, 2013

A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation
 

Business briefs: BMS, Sanofi, UK Sunshine

April 08, 2013

BMS fills week's end with shakeup and collaboration news, European regulators tamp down on rare disease drug pricing, association estimates pharma wooed UK docs with $61 million in gifts last year.
 

Business briefs: AstraZeneca, Everyday Health, J&J

April 02, 2013

AstraZeneca loses in patent court and Pulmicort goes generic, Barbara Ryan joins FTI, Everyday Health and Mayo Clinic expand their advertising alliance, analyst says Ivokana side effect could limit sales
 

Gift study shows med students still being comped

March 07, 2013

Gift bans or no, students still connect with drug companies, a study has found.
 

Sunshine spawns fresh questions for med ed

February 19, 2013

New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say.
 

CMS warms to some stakeholders, burns others with Sunshine rule

February 11, 2013

Clinical Research Organizations, marketing research firms, accredited CME providers and lawyers look to be the big winners in CMS's Sunshine Act rule.
 

Researchers find schools minting pitch-resistant docs

February 04, 2013

A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors' recommendations.
 

CMS releases "Sunshine" final rule: federal preemption, August start date

February 01, 2013

CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.
 

Business briefs: Abbott, Sunshine, Allergan and Watson

January 23, 2013

Abbott releases its 2012 numbers, Sen. Grassley demands Sunshine Act action from CMS and Allergan and Watson flex their purchasing power.
 

Company news: Edelman, CMS, McKesson

November 28, 2012

Edelman nabs a GolinHarris exec, CMS submits Sunshine regs and McKesson expands its e-coupon reach.
 

GSK's Connelly: We've changed our ways (and please don't imprison execs)

November 05, 2012

GlaxoSmithKline's Dierdre Connelly peeled back the curtain on the company's sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.
 

For Bay State, "modest meals" are in the eye of the beholder

October 25, 2012

As the Massachusetts Department of Public Health deliberates the exact shape of a rule change allowing industry-sponsored meals for physicians in speaker programs, pharma foes and industry advocates are squaring off over the definition of "modest meals and refreshments."
 

Sunshine Act could scare docs away from commercially-supported CME

September 13, 2012

Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.
 

Massachusetts gift ban under attack (again)

April 30, 2012

Massachusetts legislators aren't just sick of the Prescriptions Drug Gift Ban -- they're looking to wipe it from the books.
 

PhRMA conferees fault industry for poor messaging

April 16, 2012

PhRMA's annual meeting in Boston was full of talk about how scientific advances are pushing the boundaries of medicine's potential, but the mood was woe-is-me as members pondered their industry's poor public reputation.
 

Journal "pharmascolds" skew policy, says study

April 12, 2012

Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.
 

Study says docs favor COI disclosure

March 01, 2012

About 65% of the 1,800 physicians surveyed in a 2009 study discussed in Health Affairs support disclosing potential conflicts of interest to patients.
 

Market research kept out of Sunshine law

March 01, 2012

The Physician Payment Sunshine Act maintains the exclusion for marketing research incentives
 

Require disclosure of pharma ties, most docs say

February 14, 2012

The majority of physicians agrees that it's important to disclose to patients any financial relationships with drug and device companies but, research shows, there remains considerable rearguard sentiment to transparency.
 

Grassley blasts CMS foot-dragging on Sunshine Act

November 01, 2011

The Centers for Medicare and Medicaid Services, now a month overdue to issue draft guidelines for reporting pharma-physician contacts as required under healthcare reform legislation, said the department is working on it, but offered nothing in the way of a timeline.
 

Lilly becomes latest pharma to disclose non-cash transfers

July 29, 2011

Eli Lilly reported paying $48.1 million to 45,440 physicians and/or 1,827 healthcare organizations during the first quarter, most of it for research and educational programs.
 

In protecting market research, federal exclusion may not always apply

March 25, 2010

Thanks to the work of lobbyists, marketing research-related payments are explicitly excluded from Sunshine legislation enacted Tuesday as part of the healthcare overhaul. But the exclusion may not always apply.
 

GSK reveals speaker, consulting fees

December 15, 2009

GlaxoSmithKline said it paid nearly $15 million in fees in the second quarter to US healthcare professionals for speaking and consulting services.
 

Healthcare reform bill clears House

July 15, 2009

The House of Representatives' version of the healthcare reform bill, dubbed the America's Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising Allergy Anaphylaxis Anti-infective App ASCO Centers For Disease Control Diabetes Digital Marketing DTC Elan FDA Generic Generic Drugs Lymphoma Marketing & Communications Mobile Oncology Patient Advocacy Pipeline Regulatory Research & Development Roche